摘要
血脂异常是动脉粥样硬化性疾病重要的危险因素。回顾历史,从把不同类型的血脂指标作为心血管疾病风险预测标志物,到以低密度脂蛋白胆固醇为主要降脂靶点应用于心血管疾病的一级预防及二级预防,相关研究和临床实践提示立足分级诊疗的血脂异常管控体系是进行有效血脂管控、切实降低心脑血管疾病的重要措施。不断优化心血管疾病预测模型、加强血脂异常专病医联体建设、推广立足分级诊疗的血脂异常管控体系将有助于提升我国血脂异常整体防治水平,达到心血管疾病防治的重心下沉、关口前移,降低心血管疾病对我国居民的健康威胁。
Dyslipidemia constitutes an essential risk factor for atherosclerotic disorders.From employing diverse types of blood lipid indicators as markers for risk prediction to subsequently applying low-density lipoprotein cholesterol as the primary lipid-lowering target in both primary and secondary prevention of cardiovascular diseases,relevant research and clinical practices indicate that the dyslipidemia management system grounded on hierarchical medical care is a significant measure for effective blood lipid control and efficient reduction of cardiovascular diseases.Continuously optimizing the prediction model for cardiovascular diseases,enhancing the construction of the medical consortium specializing in dyslipidemia disorders,and promoting the dyslipidemia management and control system based on hierarchical medical treatment will facilitate elevating the overall prevention and treatment level of dyslipidemia in China,and mitigate the health menace of cardiovascular diseases for Chinese residents.
作者
张龙
李建平
ZHANG Long;LI Jianping(Department of Cardiology,Peking University First Hospital,Beijing 100000,China)
出处
《中国全科医学》
CAS
北大核心
2024年第36期4493-4497,共5页
Chinese General Practice
基金
国家重点研发计划(2021YFC2500600,2021YFC2500601)。
关键词
动脉粥样硬化性心血管疾病
血脂异常
分级诊疗
风险预测
Atherosclerotic cardiovascular disease
Dyslipidemia
Hierarchical medical treatment
Risk prediction
